These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8794431)

  • 21. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):442-8. PubMed ID: 9197447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy and urogenital disease in postmenopausal women].
    Della Martina M; Xodo S; Vogrig E; Rinuncini D; Ganzitti L; Driul L; Fabiani G; Marchesoni D
    Minerva Ginecol; 2012 Aug; 64(4):337-44. PubMed ID: 22728578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of lower urogenital changes in the menopause.
    Singh S; van Herwijnen I; Phillips C
    Menopause Int; 2013 Jun; 19(2):77-81. PubMed ID: 23778562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.
    Long CY; Liu CM; Hsu SC; Chen YH; Wu CH; Tsai EM
    Fertil Steril; 2006 Jan; 85(1):155-60. PubMed ID: 16412747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urogenital symptoms and their resulting discomfort in non-institutionalized 50-to-75-year-old Dutch women].
    van Geelen JM; van de Weijer PH; Arnolds HT
    Ned Tijdschr Geneeskd; 1996 Mar; 140(13):713-6. PubMed ID: 8668251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and determinants of urogenital symptoms in postmenopausal Islamic women.
    Aydin Y; Hassa H; Oge T; Yalcin OT; Mutlu FS
    Menopause; 2014 Feb; 21(2):182-7. PubMed ID: 23736861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between estrogen, vasomotor symptoms, and heart rate variability in climacteric women.
    Akiyoshi M; Kato K; Owa Y; Sugiyama M; Miyasaka N; Obayashi S; Kubota T; Aso T; Kimura T; Moritani T; Sato K
    J Med Dent Sci; 2011 Jul; 58(2):49-59. PubMed ID: 23896786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
    Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
    Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of hormones on urinary incontinence in postmenopausal women.
    Quinn SD; Domoney C
    Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years.
    Malmsten UG; Milsom I; Molander U; Norlén LJ
    J Urol; 1997 Nov; 158(5):1733-7. PubMed ID: 9334589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group.
    Brown JS; Grady D; Ouslander JG; Herzog AR; Varner RE; Posner SF
    Obstet Gynecol; 1999 Jul; 94(1):66-70. PubMed ID: 10389720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the climacteric influence the prevalence, incidence and type of urinary incontinence?
    Milsom I; Gyhagen M
    Climacteric; 2023 Apr; 26(2):75-79. PubMed ID: 36690015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence and determinants of genitourinary syndrome of menopause in Chinese mid-life women: a single-center study.
    Geng L; Zheng Y; Zhou Y; Li C; Tao M
    Climacteric; 2018 Oct; 21(5):478-482. PubMed ID: 29734845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between urinary incontinence and urinary tract infections, and fractures in postmenopausal women.
    Johansson C; Molander U; Milsom I; Ekelund P
    Maturitas; 1996 Apr; 23(3):265-71. PubMed ID: 8794419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Climacteric symptoms in an unselected sample of Swedish women.
    Hammar M; Berg G; Fåhraeus L; Larsson-Cohn U
    Maturitas; 1984 Dec; 6(4):345-50. PubMed ID: 6533438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
    Archer DF
    Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does obesity increase the risk of hot flashes among midlife women?: a population-based study.
    Saccomani S; Lui-Filho JF; Juliato CR; Gabiatti JR; Pedro AO; Costa-Paiva L
    Menopause; 2017 Sep; 24(9):1065-1070. PubMed ID: 28562488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.